Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 79.97 |
Low | 79.97 |
Bid | -- |
Offer | -- |
Previous close | 79.97 |
Average volume | -- |
---|---|
Shares outstanding | 72.23m |
Free float | 72.19m |
P/E (TTM) | 65.73 |
Market cap | 37.67bn CHF |
EPS (TTM) | 7.94 CHF |
Annual div (ADY) | 5.96 SGD |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | May 13 2024 |
Div pay-date | May 15 2024 |
Data delayed at least 10 minutes, as of Oct 21 2011.
More ▼
- Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
- Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024
- Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
- Lonza Nominates David Meline as Independent Board Member
- Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
- Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
- Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds
More ▼